Moderate

Precocious puberty

endocrine · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Onset of secondary sexual characteristics before age 8 in girls or 9 in boys. Central (gonadotropin-dependent) causes predominate in girls and are often idiopathic, but in boys and in rapid progression a pathological cause is more likely.

Red flags

  • Rapidly progressive puberty with marked bone age advance (threat to adult height)
  • Precocious puberty in a boy (higher chance of pathology, image the brain)
  • Neurological signs or headache (CNS lesion)
  • Signs of virilisation or an abdominal mass (tumour/CAH)

Assessment

Differential diagnosis

  • Central (gonadotropin-dependent) precocious puberty (idiopathic or CNS lesion)
  • Peripheral (gonadotropin-independent) precocious puberty (CAH, tumours, McCune-Albright)
  • Premature thelarche (isolated breast development)
  • Premature adrenarche (isolated pubic hair)
  • Exogenous sex steroid exposure
  • Hypothyroidism (severe, with precocity)
  • Normal variant early puberty

Investigations

  • Pubertal staging, growth velocity and bone age (advanced in true precocity)
  • Basal and GnRH-stimulated LH/FSH to classify central vs peripheral
  • Oestradiol/testosterone levels
  • Pelvic ultrasound (girls) for uterine/ovarian maturation
  • MRI brain for central precocity (especially boys or neurological features)
  • 17-OHP, adrenal androgens, hCG, thyroid function as directed

Management

  • Confirm true pubertal development and distinguish from benign variants
  • Assess growth acceleration and advanced bone age
  • Measure gonadotropins (basal and stimulated) to classify central vs peripheral
  • Measure sex steroids and seek a peripheral source if gonadotropin-independent
  • Image the brain for central precocity, especially in boys
  • Investigate peripheral causes (adrenal, gonadal, CAH, McCune-Albright)
  • Refer to paediatric endocrinology
  • Treat central precocious puberty with GnRH analogues to halt progression and preserve height
  • Treat the underlying cause of peripheral precocity

Drugs & doses

GnRH analogue (e.g. leuprorelin/triptorelin depot) to suppress central precocious puberty (specialist)
Treat underlying cause for peripheral precocity (e.g. hydrocortisone for CAH)
Aromatase inhibitors/anti-androgens in selected peripheral causes (specialist)
No treatment for benign premature thelarche/adrenarche; monitor

Disposition

Paediatric endocrinology referral; expedite for boys, rapid progression, or neurological features.

Complications & pitfalls

  • Reduced final adult height from premature epiphyseal fusion
  • Psychosocial difficulties from early maturation
  • Underlying serious pathology (CNS or adrenal/gonadal tumour)
  • Progression of untreated peripheral cause

Exam pearls

  • Precocious puberty in boys is more likely pathological and warrants brain imaging
  • Isolated breast development (premature thelarche) in a young girl is usually benign and non-progressive
  • Advanced bone age with rapid progression threatens final height and favours treatment
  • A GnRH stimulation test distinguishes central from peripheral causes

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.